Merck's Continuous Process Improvement - Life Science Leader
WEBJul 1, 2014 — Merck embraced a process of continuous improvement after years of implementing Lean initiatives that yielded periodic improvements. With Lean, Six Sigma, Kaizen, Agile, total quality management, and other process improvement approaches, after an initial surge, results sometimes slipped backwards to baseline levels.
Life Science Leader - Home Page
WEBVolastra Therapeutics is a drug discovery and development leader in the emerging field of chromosomal instability, a phenomenon that can determine how certain solid tumor cancer cells replicate and grow. OSE Immunotherapeutics is poised to begin a confirmatory and pivotal Phase 3 trial for a novel cancer vaccine targeting the second line in ...
Inside Takeda Oncology's Patient Advocacy Program - Life Science …
WEBDec 29, 2016 — One of the most important components of Takeda Oncology’s patient advocacy initiative is its patient ambassadors, of whom the company currently has about 30. Ambassadors speak at educational seminars and medical meetings, patient events, and to patient support groups about their experience to create awareness of multiple myeloma.
Ahead Of The Curve On Radiopharmaceuticals - Life Science Leader
WEBJan 1, 2024 — Despite the negatives – a complicated supply chain, short half-life, and the radioactive fear factor – analysts are forecasting continued growth in radiopharmaceuticals (from approximately $5-7 billion in 2022 to $9-$13 billion in 2032), amid a shift in focus from diagnostics to therapeutics. In late December, Bristol Myers Squibb announced ...
Where Are They Now? SQZ Biotech - lifescienceleader.com
WEBMay 1, 2024 — In 2020, Sharei took SQZ Biotech public with a $71 million IPO, and channeled the funds into its pipeline of novel cell therapies. Being the founder and CEO of SQZ Biotech was Sharei’s first full-time job, and it was “all-consuming,” noted Sharei in the 2019 article. “People often applaud entrepreneurship, lionize its leaders, and paint ...
Companies To Watch: Volastra Therapeutics - Life Science Leader
WEBJun 26, 2024 — By Ben Comer, Chief Editor, Life Science Leader. Charles Hugh-Jones. Developing biomarkers and therapies targeting chromosomal instability, a hallmark of cancer cell replication. Snapshot. New York City-based Volastra Therapeutics – whose founders and scientific advisors are leading chromosomal instability researchers and experts – have in four years’ time advanced two drug candidates ...
A Proactive Approach To 'Unscrupulous' Patent Practices
WEBMar 7, 2024 — A Proactive Approach To 'Unscrupulous' Patent Practices. By Ben Comer, Chief Editor, Life Science Leader. Terran Biosciences founder and CEO Sam Clark, MD, Ph.D., believes his organization has engineered a way to sidestep a long-running patent ploy used by branded drugmakers to delay generic competitors from entering the …
How — And Why — John Oyler Built BeiGene - Life Science Leader
WEBNov 1, 2019 — AN ALL-IN COMMITMENT FROM A PHARMA CEO. In 2010 when John Oyler first started seeking investors for his new company, BeiGene, he also made an important commitment to his cofounder and the rest of the team. “I told them that I’d put every penny I had at risk, which was $10 million,” he says.
Pharmaceutical Scientists' Salaries in 2023
WEBJan 15, 2024 — In fact, salaries were up among industry scientists as well as academic scientists (AAPS members) – mean annual base salary from principle, full-time employment in the U.S. as of June 1 (the date of the survey cut off) was $190,100, a 6.7% increase from 2022 ($178,100). Pharmaceutical scientists outside of the U.S. had average base salaries ...
A Systems Approach To Parkinson's Disease - Life Science Leader
WEBAug 30, 2024 — By Ben Comer, Chief Editor, Life Science Leader. Alex Martinez. In August 2023, Gut, a journal published by BMJ, released a study of over 24,000 patients with Parkinson’s disease, finding that certain gastrointestinal disorders — such as difficulty swallowing, constipation, and irritable bowel syndrome (IBS) — might specifically predict Parkinson’s disease.